Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print

Industry News

Related Searches:

Filter by:

Schering-Plough To Cut More Costs
April 3, 2008
Schering-Plough has launched a new Productivity Transformation Program (PTP) to cut costs and increase productivity in an effort to save $1.5 billion annually. The program is in response to intensifying pressures in the U.S. market, centering on the…   Read More »
Akorn Signs Supply Pact With Fresenius Kabi
April 3, 2008
Akorn, Inc. has signed a five-year supply agreement with Fresenius Kabi for a new premix product. Premix medications are ready to use intravenous drug products.     Under the terms of the agreement, Akorn will be responsible for de…   Read More »
Metrics Expands Stability Storage
April 3, 2008
Metrics, Inc. is expanding its stability storage, boosting its capacity for service by 50%. The $18-million, 47,000-sq.-ft. expansion will include new state-of-the-art environmental specialties (ESI) chambers with redundant mechanical systems that wi…   Read More »
Teva To Buy Bentley
March 31, 2008
Teva Pharmaceutical Industries Ltd. has entered an agreement to buy Bentley Pharmaceuticals. The move will follow the spin-off of Bentley's drug delivery business, which was announced in October 2007. Teva will spend approximately $360 million to acq…   Read More »
Cambrex Customer Recalls Product
March 24, 2008
Cambrex Corp. announced that one of its customers is recalling a product for which Cambrex currently supplies the active pharmaceutical ingredient (API). The recall decision is not linked to Cambrex's performance as the manufacturer of the API. The r…   Read More »
Akorn Inks OTC Manufacturing Deal
March 24, 2008
Akorn, Inc. has signed a five-year commercial manufacturing and supply agreement with a U.S. ophthalmic company. Under the terms of the agreement, Akorn will be responsible for the manufacture and supply of three OTC eye care products. The products w…   Read More »
Takeda, Abbott To Terminate JV
March 20, 2008
Takeda Pharmaceutical Co. Ltd. and Abbott entered an agreement to conclude their TAP Pharmaceutical Products Inc. (TAP) joint venture, which was established in 1977. The companies expect the transaction to close within 30-60 days. Takeda plans to int…   Read More »
PRA Opens New Office In Mumbai
March 20, 2008
PRA has moved its Mumbai, India office to a larger, more centrally located facility. The new location is triple the size and includes more offices and conference and meeting spaces, and will accommodate the Mumbai team of 20 clinical operations staff…   Read More »
Alkermes Restructures After Lilly Exit
March 19, 2008
Alkermes, Inc. is restructuring its operations after partner Eli Lilly and Co. terminated the AIR Insulin program. Alkermes is reducing its staff by approximately 18% (150 employees) and closing its AIR commercial manufacturing facility in Chelsea, M…   Read More »
Archimica To Supply API For NicOx Drug
March 19, 2008
NicOx S.A. has signed an agreement with Archimica for the commercial manufacturing and supply of naproxcinod API. Naproxcinod is NicOx's lead candidate in the COX-Inhibiting Nitric Oxide-Donating (CINOD) class of anti-inflammatory agents. NicOx expec…   Read More »
InVentiv Clinical Expands Operations
March 13, 2008
inVentiv Clinical Solutions, LLC will establish operations in the growing region of Latin America. The new location will be based in Sao Paulo, Brazil, with the plan to expand operations to other Latin American countries. The Latin American operation…   Read More »
Advion Acquires Washburn
March 12, 2008
Advion BioSciences, Inc., through its BioSystems subsidiary, has acquired certain assets of its manufacturing partner, Washburn Manufacturing Technologies, Inc. Under the terms of agreement, Advion BioSystems will absorb the manufacturing operation a…   Read More »
Tufts Study Finds MAbs Development On The Rise
March 11, 2008
According to Tufts Center for the Study of Drug Development (Tufts CSDD) the number of monoclonal antibody products in development nearly tripled in the last decade. A recent Tufts CSDD study found that monoclonal antibody products, referred to as mA…   Read More »
Eusa Pharma To Acquire Cytogen
March 11, 2008
Eusa Pharma, Inc. has entered into a definitive agreement to acquire all the outstanding shares of Cytogen Corp. for $22.6 million cash. Cytogen has three oncology and pain control products on the U.S. market, a specialized oncology sales force, and…   Read More »
Amgen To License MAb From Kyowa Hakko
March 6, 2008
Amgen has entered an exclusive licensing agreement to develop and commercialize Kyowa Hakko Kogyo Co.'s humanized monoclonal antibody KW-0761 worldwide, except in Japan, Korea, China and Taiwan, where Kyowa Hakko will retain development and commercia…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: